STEPHANIE DAVIS: Open Payments
NPI 1184928921 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 22 payments from 16 companies in 2025. Trend: 2023 $1,164 · 2024 $1,075 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $149 |
| KYOWA KIRIN, INC. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $116 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| PFIZER INC. | 3 | $83 |
| Dexcom, Inc. | 1 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Novo Nordisk Inc | 2 | $30 |
| Medtronic, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
Products named: VOQUEZNA, Epclusa, Auvelity, DEXCOM G7 GSS (161), NURTEC ODT, AIRSUPRA, SYMPLICITY G3, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
